Position in OGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$50,761
+$28,628 QoQ
Shares Held
3,749
+1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#291
of 626 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROTHSCHILD INVESTMENT LLC holds $124,173,340 across 16 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
122,435 | $30,809,543 | |
| 2 | JNJ |
Johnson & Johnson
|
96,818 | $24,588,867 | |
| 3 | AMGN |
Amgen Inc
|
59,073 | $21,391,514 | |
| 4 | LLY |
ELI LILLY & Co
|
15,725 | $18,861,038 | |
| 5 | MRK |
Merck & Co., Inc.
|
96,633 | $12,417,340 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
96,905 | $5,583,666 | |
| 7 | PFE |
Pfizer Inc
|
211,962 | $5,104,044 | |
| 8 | NVS |
Novartis AG
|
16,578 | $2,598,104 |
All Filings in OGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,761 | 3,749 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $22,133 | 3,695 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $21,086 | 2,941 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $41,641 | 3,899 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $21,809 | 2,253 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $33,249 | 2,233 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $33,167 | 2,223 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $50,139 | 2,621 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $54,151 | 2,616 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $51,004 | 2,713 | Shares | Sole | 2024-07-31 | |
| 2023-12-31 | $39,265 | 2,723 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||